Cargando…
iPSCs from people with MS can differentiate into oligodendrocytes in a homeostatic but not an inflammatory milieu
Multiple sclerosis (MS) is an inflammatory and demyelinating disease of the central nervous system (CNS) that results in variable severities of neurodegeneration. The understanding of MS has been limited by the inaccessibility of the affected cells and the lengthy timeframe of disease development. H...
Autores principales: | Morales Pantoja, Itzy E., Smith, Matthew D., Rajbhandari, Labchan, Cheng, Linzhao, Gao, Yongxing, Mahairaki, Vasiliki, Venkatesan, Arun, Calabresi, Peter A., Fitzgerald, Kathryn C., Whartenby, Katharine A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7279569/ https://www.ncbi.nlm.nih.gov/pubmed/32511247 http://dx.doi.org/10.1371/journal.pone.0233980 |
Ejemplares similares
-
Enhanced axonal regeneration of ALS patient iPSC-derived motor neurons harboring SOD1(A4V) mutation
por: Marshall, Katherine L., et al.
Publicado: (2023) -
Lucky iPSCs
por: Zviran, Asaf, et al.
Publicado: (2014) -
iPSCs are safe!
por: Yan, Hualong, et al.
Publicado: (2017) -
Single-cell transcriptomic reveals molecular diversity and developmental heterogeneity of human stem cell-derived oligodendrocyte lineage cells
por: Chamling, Xitiz, et al.
Publicado: (2021) -
The role of mutations associated with familial neurodegenerative disorders on blood–brain barrier function in an iPSC model
por: Katt, Moriah E., et al.
Publicado: (2019)